FS KKR Capital Earnings Calls
| Release date | May 11, 2026 |
| EPS estimate | $0.440 |
| EPS actual | $0.410 |
| EPS Surprise | -6.82% |
| Revenue estimate | 316.811M |
| Revenue actual | 304M |
| Revenue Surprise | -4.04% |
| Release date | Feb 25, 2026 |
| EPS estimate | $0.550 |
| EPS actual | $0.520 |
| EPS Surprise | -5.45% |
| Revenue estimate | 361.831M |
| Revenue actual | 348M |
| Revenue Surprise | -3.82% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.570 |
| EPS actual | $0.570 |
| Revenue estimate | 361.589M |
| Revenue actual | 344M |
| Revenue Surprise | -4.86% |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.630 |
| EPS actual | -$0.600 |
| EPS Surprise | -195.24% |
| Revenue estimate | 402.002M |
| Revenue actual | 260M |
| Revenue Surprise | -35.32% |
Last 4 Quarters for FS KKR Capital
Below you can see how FSK performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $20.24 |
| EPS estimate | $0.630 |
| EPS actual | -$0.600 |
| EPS surprise | -195.24% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $20.91 |
| Aug 01, 2025 | $20.50 |
| Aug 04, 2025 | $20.08 |
| Aug 05, 2025 | $20.14 |
| Aug 06, 2025 | $20.24 |
| Aug 07, 2025 | $18.58 |
| Aug 08, 2025 | $17.89 |
| Aug 11, 2025 | $17.55 |
| Aug 12, 2025 | $17.72 |
| 4 days before | -3.20% |
| 4 days after | -12.45% |
| On release day | -8.20% |
| Change in period | -15.26% |
| Release date | Nov 05, 2025 |
| Price on release | $14.79 |
| EPS estimate | $0.570 |
| EPS actual | $0.570 |
| Date | Price |
|---|---|
| Oct 30, 2025 | $15.06 |
| Oct 31, 2025 | $15.09 |
| Nov 03, 2025 | $15.11 |
| Nov 04, 2025 | $14.92 |
| Nov 05, 2025 | $14.79 |
| Nov 06, 2025 | $15.21 |
| Nov 07, 2025 | $15.23 |
| Nov 10, 2025 | $15.38 |
| Nov 11, 2025 | $15.49 |
| 4 days before | -1.79% |
| 4 days after | 4.73% |
| On release day | 2.84% |
| Change in period | 2.86% |
| Release date | Feb 25, 2026 |
| Price on release | $13.32 |
| EPS estimate | $0.550 |
| EPS actual | $0.520 |
| EPS surprise | -5.45% |
| Date | Price |
|---|---|
| Feb 19, 2026 | $13.16 |
| Feb 20, 2026 | $12.97 |
| Feb 23, 2026 | $12.84 |
| Feb 24, 2026 | $13.12 |
| Feb 25, 2026 | $13.32 |
| Feb 26, 2026 | $11.29 |
| Feb 27, 2026 | $10.80 |
| Mar 02, 2026 | $10.85 |
| Mar 03, 2026 | $10.95 |
| 4 days before | 1.22% |
| 4 days after | -17.79% |
| On release day | -15.24% |
| Change in period | -16.79% |
| Release date | May 11, 2026 |
| Price on release | $10.76 |
| EPS estimate | $0.440 |
| EPS actual | $0.410 |
| EPS surprise | -6.82% |
| Date | Price |
|---|---|
| May 05, 2026 | $11.50 |
| May 06, 2026 | $11.42 |
| May 07, 2026 | $10.94 |
| May 08, 2026 | $10.84 |
| May 11, 2026 | $10.76 |
| May 12, 2026 | $10.78 |
| May 13, 2026 | $10.72 |
| May 14, 2026 | $10.80 |
| May 15, 2026 | $10.98 |
| 4 days before | -6.43% |
| 4 days after | 2.04% |
| On release day | 0.186% |
| Change in period | -4.52% |
FS KKR Capital Earnings Call Transcript Summary of Q1 2026
Key points for investors: FSK reported a challenging Q1 2026: NAV fell 9.9% to $18.83 per share and GAAP net investment income (NII) was $0.42 per share. The Board declared a Q2 distribution of $0.42 (consistent with paying 100% of GAAP NII). Management and KKR announced a four-part strategic package designed to stabilize the fund: (1) KKR to commence a $150 million fixed-price tender offer at $11 per share to provide liquidity and signal value; (2) KKR to invest $150 million via a cumulative convertible preferred security (initial conversion price $18.83, starting dividend 5% cash or 7% PIK); (3) a $300 million share repurchase authorization to be executed after the tender, funded in part by convertible preferred proceeds and investment repayments; and (4) a temporary waiver (four quarters) of 50% of the subordinated income incentive fee to support NII and distributions. Portfolio drivers: the NAV decline was driven by company-specific credit events (notably legacy and certain 2021–2022 vintage loans) and mark-to-market spread moves. Specific underperformers called out include Medallia (placed on nonaccrual), ATX and Production Resource Group (PRG) — together significant contributors to the NAV decline. Nonaccruals increased to 8.1% of portfolio on a cost basis (4.2% on a fair value basis). Portfolio composition and liquidity: fair value portfolio $12.3B across 236 companies; ~60% first-lien loans (69% first lien when including joint venture look-through) and ~64% senior secured; weighted average yield on accruing debt 9.7%; gross/net debt-to-equity ~138%/131%; pro forma liquidity after credit amendment $2.3B. Near-term posture and outlook: management will reduce new originations, prioritize portfolio support and rotation, lower leverage and execute buybacks as repayments arrive. They expect Q2 net repayments >$500M and project NII on an annualized basis of roughly 8–9% of NAV going forward (subject to market/portfolio variability). Management emphasized this is a transitional period; the fund may be smaller over time but should have a stronger balance sheet and improved trading profile if actions are executed.
Sign In
Buy FSK